Partly Fermented Infant Formulae With Specific Oligosaccharides Support Adequate Infant Growth and Are Well-Tolerated.

Details

Ressource 1Download: 27472478_BIB_7A0165956B8F.pdf (539.01 [Ko])
State: Public
Version: Final published version
Serval ID
serval:BIB_7A0165956B8F
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Partly Fermented Infant Formulae With Specific Oligosaccharides Support Adequate Infant Growth and Are Well-Tolerated.
Journal
Journal of pediatric gastroenterology and nutrition
Author(s)
Huet F., Abrahamse-Berkeveld M., Tims S., Simeoni U., Beley G., Savagner C., Vandenplas Y., Hourihane J.O.
ISSN
1536-4801 (Electronic)
ISSN-L
0277-2116
Publication state
Published
Issued date
10/2016
Peer-reviewed
Oui
Volume
63
Number
4
Pages
e43-53
Language
english
Notes
Publication types: Comparative Study ; Journal Article ; Multicenter Study ; Randomized Controlled Trial
Publication Status: ppublish
Abstract
Fermented formulae (FERM) and a specific mixture of 90% short-chain galacto-oligosaccharides and 10% long-chain fructo-oligosaccharides (scGOS/lcFOS; 9:1) have a potential beneficial effect on gastrointestinal function and microbiota development in infants. The present study assessed the safety and tolerance of the combination of partly fermented infant milk formulae and scGOS/lcFOS compared with either 1 feature, in healthy term infants.
Four hundred thirty-two infants were enrolled before 28 days of age and followed up to 17 weeks of age and assigned to 1 of the 4 groups: (i) formula with scGOS/lcFOS, (ii) scGOS/lcFOS + 15% FERM, (iii) scGOS/lcFOS + 50% FERM, or (iv) 50% fermented formula (50% FERM). Primary outcome was daily weight gain during intervention (equivalence criterion: difference in daily weight gain ≤3 g/day). Infants' anthropometrics, formula intake, number, and type of (serious) AEs were monitored monthly. Stool samples were collected at baseline and after 17 weeks for analysis of physiological and microbiological parameters.
Equivalence of weight gain per day was demonstrated in both the intention-to-treat and per-protocol population, with a mean weight gain (SD) of 29.7 (6.1), 28.2 (4.8), 28.5 (5.0), and 28.7 (5.9) g/day for the groups i to iv respectively. No differences were observed in other growth parameters, formula intake, and the number or severity of AEs. In all scGOS/lcFOS-containing formulae, a beneficial effect of scGOS/lcFOS was observed, indicated by the lower pH, lower Clostridium difficile levels, and higher secretory immunoglobulin A levels.
The partly fermented infant milk formulae containing the specific mixture scGOS/lcFOS were well-tolerated and resulted in normal growth in healthy infants.

Keywords
Clostridium difficile/isolation & purification, Double-Blind Method, Feces/microbiology, Female, Follow-Up Studies, Humans, Infant, Infant Formula/adverse effects, Infant, Newborn, Male, Oligosaccharides/adverse effects, Outcome Assessment (Health Care), Prospective Studies, Weight Gain
Pubmed
Web of science
Create date
07/10/2016 15:54
Last modification date
20/08/2019 14:36
Usage data